A Yap-Myc-Sox2-p53 Regulatory Network Dictates Metabolic Homeostasis and Differentiation in Kras-Driven Pancreatic Ductal Adenocarcinomas.
暂无分享,去创建一个
Shannon M. White | D. Saur | M. Pende | G. Graham | S. Murakami | Chunling Yi | I. Nemazanyy | Hengye Chen | Chan D K Nguyen
[1] Shannon M. White,et al. YAP/TAZ Inhibition Induces Metabolic and Signaling Rewiring Resulting in Targetable Vulnerabilities in NF2-Deficient Tumor Cells. , 2019, Developmental cell.
[2] Shannon M. White,et al. The complex entanglement of Hippo-Yap/Taz signaling in tumor immunity , 2019, Oncogene.
[3] R. Weinberg,et al. Epithelial-to-mesenchymal transition in cancer: complexity and opportunities , 2018, Frontiers of Medicine.
[4] G. Eibl,et al. Yes-associated protein (YAP) in pancreatic cancer: at the epicenter of a targetable signaling network associated with patient survival , 2018, Signal Transduction and Targeted Therapy.
[5] R. Premont,et al. Hedgehog-YAP Signaling Pathway Regulates Glutaminolysis to Control Activation of Hepatic Stellate Cells. , 2018, Gastroenterology.
[6] J. Park,et al. The Role of Hippo Pathway in Cancer Stem Cell Biology , 2018, Molecules and cells.
[7] Ho-Joon Lee,et al. Mutant p53R270H drives altered metabolism and increased invasion in pancreatic ductal adenocarcinoma , 2018, JCI insight.
[8] Mathias J Friedrich,et al. Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes , 2018, Nature.
[9] Karl-Heinz Krause,et al. Glut3 Addiction Is a Druggable Vulnerability for a Molecularly Defined Subpopulation of Glioblastoma. , 2017, Cancer cell.
[10] E. Shiuan,et al. The receptor tyrosine kinase EphA2 promotes glutamine metabolism in tumors by activating the transcriptional coactivators YAP and TAZ , 2017, Science Signaling.
[11] G. Evan,et al. Myc Cooperates with Ras by Programming Inflammation and Immune Suppression , 2017, Cell.
[12] F. Biagioni,et al. Transcriptional integration of mitogenic and mechanical signals by Myc and YAP , 2017, Genes & development.
[13] L. Wood,et al. A p53 Super-tumor Suppressor Reveals a Tumor Suppressive p53-Ptpn14-Yap Axis in Pancreatic Cancer. , 2017, Cancer cell.
[14] M. Tomita,et al. Global metabolic reprogramming of colorectal cancer occurs at adenoma stage and is induced by MYC , 2017, Proceedings of the National Academy of Sciences.
[15] Xuexiang Han,et al. A combinatorial strategy using YAP and pan-RAF inhibitors for treating KRAS-mutant pancreatic cancer. , 2017, Cancer letters.
[16] Songchuan Guo,et al. Immunotherapy in pancreatic cancer: Unleash its potential through novel combinations , 2017, World journal of clinical oncology.
[17] O. Sansom,et al. Modulating the therapeutic response of tumours to dietary serine and glycine starvation , 2017, Nature.
[18] A. Rizzino,et al. The dark side of SOX2: cancer - a comprehensive overview , 2017, Oncotarget.
[19] R. Klose,et al. The pioneer factor OCT4 requires the chromatin remodeller BRG1 to support gene regulatory element function in mouse embryonic stem cells , 2017, eLife.
[20] J. Ernst,et al. Cooperative Binding of Transcription Factors Orchestrates Reprogramming , 2017, Cell.
[21] C. Lyssiotis,et al. Employing Metabolism to Improve the Diagnosis and Treatment of Pancreatic Cancer. , 2017, Cancer cell.
[22] Shannon M. White,et al. Rac1-Mediated DNA Damage and Inflammation Promote Nf2 Tumorigenesis but Also Limit Cell-Cycle Progression. , 2016, Developmental cell.
[23] S. Manley,et al. A role for mitotic bookmarking of SOX2 in pluripotency and differentiation , 2016, Genes & development.
[24] M. Peinado,et al. DNA methylation dynamics in cellular commitment and differentiation. , 2016, Briefings in functional genomics.
[25] B. Spencer‐Dene,et al. YAP1 and TAZ Control Pancreatic Cancer Initiation in Mice by Direct Up-regulation of JAK–STAT3 Signaling , 2016, Gastroenterology.
[26] John M. Asara,et al. Yap reprograms glutamine metabolism to increase nucleotide biosynthesis and enable liver growth , 2016, Nature Cell Biology.
[27] Shannon M. White,et al. Yes-Associated Protein Mediates Immune Reprogramming in Pancreatic Ductal Adenocarcinoma , 2016, Oncogene.
[28] Stefano Piccolo,et al. YAP/TAZ at the Roots of Cancer. , 2016, Cancer cell.
[29] R. Gibbs,et al. Genomic analyses identify molecular subtypes of pancreatic cancer , 2016, Nature.
[30] Howard Y. Chang,et al. The histone chaperone CAF-1 safeguards somatic cell identity , 2015, Nature.
[31] C. Dang,et al. MYC, Metabolism, and Cancer. , 2015, Cancer discovery.
[32] Antonio Rosato,et al. Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth , 2015, Nature Cell Biology.
[33] M. Karin,et al. A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis , 2015, Genes & development.
[34] W. Bamlet,et al. Antithetical NFATc1–Sox2 and p53–miR200 signaling networks govern pancreatic cancer cell plasticity , 2015, The EMBO journal.
[35] Randy L. Johnson,et al. AMPK modulates Hippo pathway activity to regulate energy homeostasis , 2015, Nature Cell Biology.
[36] Matthew E. Ritchie,et al. limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.
[37] D. Corey,et al. C-MYC Transcriptionally Amplifies SOX2 Target Genes to Regulate Self-Renewal in Multipotent Otic Progenitor Cells , 2014, Stem cell reports.
[38] Yanli Wang,et al. Topologically associating domains are stable units of replication-timing regulation , 2014, Nature.
[39] Christian Veltkamp,et al. A next-generation dual-recombinase system for time- and host-specific targeting of pancreatic cancer , 2014, Nature Medicine.
[40] Shan Jiang,et al. Yap1 Activation Enables Bypass of Oncogenic Kras Addiction in Pancreatic Cancer , 2014, Cell.
[41] Patrick Cahan,et al. Hippo Pathway Activity Influences Liver Cell Fate , 2014, Cell.
[42] Joseph Rosenbluh,et al. KRAS and YAP1 Converge to Regulate EMT and Tumor Survival , 2014, Cell.
[43] A. Wellstein,et al. Downstream of Mutant KRAS, the Transcription Regulator YAP Is Essential for Neoplastic Progression to Pancreatic Ductal Adenocarcinoma , 2014, Science Signaling.
[44] Timothy E. Reddy,et al. Distinct properties of cell-type-specific and shared transcription factor binding sites. , 2013, Molecular cell.
[45] W. Bamlet,et al. SOX2 promotes dedifferentiation and imparts stem cell-like features to pancreatic cancer cells , 2013, Oncogenesis.
[46] P. Robson,et al. Oct4 switches partnering from Sox2 to Sox17 to reinterpret the enhancer code and specify endoderm , 2013, The EMBO journal.
[47] John M. Asara,et al. Glutamine supports pancreatic cancer growth through a Kras-regulated metabolic pathway , 2013, Nature.
[48] G. Evan,et al. Inhibition of Myc family proteins eradicates KRas-driven lung cancer in mice. , 2013, Genes & development.
[49] A. Üren,et al. Quantifying the CDK inhibitor VMY-1-103’s activity and tissue levels in an in vivo tumor model by LC-MS/MS and by MRI , 2012, Cell cycle.
[50] Data production leads,et al. An integrated encyclopedia of DNA elements in the human genome , 2012 .
[51] ENCODEConsortium,et al. An Integrated Encyclopedia of DNA Elements in the Human Genome , 2012, Nature.
[52] Gerald C. Chu,et al. Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism , 2012, Cell.
[53] Bond-Smith Giles,et al. Only women with symptoms need to have their breast implants removed, says government , 2012 .
[54] C. Galbán,et al. Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice. , 2012, The Journal of clinical investigation.
[55] M. C. Jørgensen,et al. Ptf1a-mediated control of Dll1 reveals an alternative to the lateral inhibition mechanism , 2012, Development.
[56] L. Johnston,et al. Evidence for a growth-stabilizing regulatory feedback mechanism between Myc and Yorkie, the Drosophila homolog of Yap. , 2010, Developmental cell.
[57] M. Giovannini,et al. The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals. , 2010, Developmental cell.
[58] Gerald C. Chu,et al. Context-dependent transformation of adult pancreatic cells by oncogenic K-Ras. , 2009, Cancer cell.
[59] A. Regev,et al. SOX2 Is an Amplified Lineage Survival Oncogene in Lung and Esophageal Squamous Cell Carcinomas , 2009, Nature Genetics.
[60] G. Feldmann,et al. Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult mice , 2008, Proceedings of the National Academy of Sciences.
[61] G. Evan,et al. Modelling Myc inhibition as a cancer therapy , 2008, Nature.
[62] M. Barbacid,et al. Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice. , 2007, Cancer cell.
[63] Jianmin Zhang,et al. Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon , 2006, Proceedings of the National Academy of Sciences.
[64] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[65] W. Hahn,et al. Transformation of Human and Murine Fibroblasts without Viral Oncoproteins , 2005, Molecular and Cellular Biology.
[66] R. Hruban,et al. Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. , 2005, Cancer cell.
[67] R. DePinho,et al. Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma. , 2003, Genes & development.
[68] E. Petricoin,et al. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. , 2003, Cancer cell.
[69] M. Daly,et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.
[70] L. Papagiannoulis,et al. Multifactorial analysis of the aetiology of craniomandibular dysfunction in children. , 2002, International journal of paediatric dentistry.
[71] P. Froguel,et al. Defective insulin secretion in hepatocyte nuclear factor 1alpha-deficient mice. , 1998, The Journal of clinical investigation.
[72] E. Gottlieb,et al. Analysis of Cell Metabolism Using LC-MS and Isotope Tracers. , 2015, Methods in enzymology.
[73] N. Bardeesy,et al. Pancreatic adenocarcinoma. , 2014, The New England journal of medicine.
[74] B. Croy,et al. Evaluation of the pregnancy immunotrophism hypothesis by assessment of the reproductive performance of young adult mice of genotype scid/scid.bg/bg. , 1990, Journal of reproduction and fertility.